Neil Sheth, MD
Orthopaedic Surgery · Philadelphia, PANPI 1881754463
Payments from drug & device makers
Across 581 payments — averaging $1089.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$295K
- Zimmer Biomet$157K
- Smith+Nephew$138K
- Radius Health, Inc.$16K
- Sanofi US Services Inc.$12K
- Microport Orthopedics Inc$8K
- plus $8K from 21 others
Across 15 payments — averaging $10,880 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medacta USA, Inc.$163K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 141 | $294,725 |
| Zimmer Biomet | 194 | $156,522 |
| Smith+Nephew | 121 | $138,205 |
| Radius Health, Inc. | 41 | $15,686 |
| Sanofi US Services Inc. | 20 | $12,249 |
| Microport Orthopedics Inc | 11 | $8,307 |
| Synthes GmbH | 4 | $3,444 |
| Onkos Surgical, Inc. | 6 | $1,365 |
| Stryker | 8 | $883 |
| Orthalign Inc | 2 | $309 |
| Heraeus Medical, LLC. | 11 | $229 |
| Convatec Inc. | 2 | $195 |
| Linkbio Corp | 1 | $179 |
| Si-bone, Inc. | 1 | $145 |
| BD | 3 | $129 |
| Pacira Pharmaceuticals Incorporated | 1 | $122 |
| Medtronic(2 entities) | 3 | $112 |
| Anx Robotica Corp | 1 | $102 |
| Novartis | 1 | $101 |
| Johnson & Johnson | 2 | $74 |
| Medical Device Business Services, Inc. | 1 | $48 |
| Bioventus LLC | 1 | $33 |
| KCI USA, Inc. | 1 | $31 |
| Baxter Healthcare | 1 | $26 |
| Abbott | 1 | $21 |
| Bsn Medical Inc | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$633,273 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Philadelphia
- John FenlinPhiladelphia$5.9M
- Alexander VaccaroPhiladelphia$4.5M
- Joseph AbboudPhiladelphia$4.1M
- Samir MehtaPhiladelphia$3.7M
- Surena NamdariPhiladelphia$1.8M
- Craig IsraelitePhiladelphia$938K
- Andrew KuntzPhiladelphia$732K
- Vahid EntezariPhiladelphia$487K
- Amrit KhalsaPhiladelphia$475K
- Charles NelsonPhiladelphia$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.